Biomarkers can help a treatment team to determine the best treatment for a patient, see how the patient is responding, and assist in creating a care plan. New tumor markers are being identified with more frequency, so all tumor markers may not yet be reflected on this list.
- AFP-L3
- Alpha-fetoprotein (AFP)
- AKR1B10
- Annexin A2
- APEX1
- Des-γ-carboxyprothrombin (DCP)
- Cytokeeratin 19
- GALAD
- Glypican-1
- Golgi Protein 73
- HMGB3
- Midkine
- miRNAs
- NTRK
- Osteopontin
- Programmed death ligand 1 (PD-L1)
- Squamous Cell Carcinoma Antigen (SCCA)